Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. - Wikidata - wikimedia - TriplyDB

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

http://www.wikidata.org/entity/Q34578123

about

Human-specific histone methylation signatures at transcription start sites in prefrontal neurons Neuropeptide regulation of signaling and behavior in the BNST.Emerging roles of ARHGAP33 in intracellular trafficking of TrkB and pathophysiology of neuropsychiatric disorders.Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice.The p250GAP gene is associated with risk for schizophrenia and schizotypal personality traits Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia.Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice.Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.Variants of the RELA gene are associated with schizophrenia and their startle responses Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects Homeodomain protein otp and activity-dependent splicing modulate neuronal adaptation to stress.Increased stathmin1 expression in the dentate gyrus of mice causes abnormal axonal arborizations PACAP in the BNST produces anorexia and weight loss in male and female rats.Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies PAC1 receptor (ADCYAP1R1) genotype and problematic alcohol use in a sample of young women Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment.Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo.Neuropeptides shaping the central nervous system development: Spatiotemporal actions of VIP and PACAP through complementary signaling pathways.Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells.VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.PACAP is implicated in the stress axes.PACAP enhances axon outgrowth in cultured hippocampal neurons to a comparable extent as BDNF.Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at Adulthood DEGS2 polymorphism associated with cognition in schizophrenia is associated with gene expression in brain Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation.A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia Double In situ Hybridization for MicroRNAs and mRNAs in Brain Tissues.Stress-related disorders, pituitary adenylate cyclase-activating peptide (PACAP)ergic system, and sex differences.Role of the PACAP-PAC1-DISC1 and PACAP-PAC1-stathmin1 systems in schizophrenia and bipolar disorder: novel treatment mechanisms?Molecular basis of major psychiatric diseases such as schizophrenia and depression.The plover neurotranscriptome assembly: transcriptomic analysis in an ecological model species without a reference genome.

P2860

Q21563522-8814ADD7-CB89-4BF2-9177-5D2A51C1EEA7 Q26866326-8D16BEE0-5DE1-4549-9482-FEF80FD82C27 Q27333743-BD0D767B-A063-4308-A3D1-D274D43E7C4D Q28083843-6C3C48F9-35FB-4F3B-BEB8-75C39C03D0E9 Q28304430-C52EEE27-82E6-4706-833E-1516B3F031C3 Q28539999-F4D807C6-3390-4ABC-871B-D85F6FF03225 Q28730526-8F02F2D6-AB5A-4ED8-A527-38BEA543EA37 Q28732849-3AC39F09-35AC-40BD-88BE-191512B6E652 Q28756538-4F07E22C-D25A-41C5-A69A-9ADAF8C9E11B Q30408057-DA4BB953-248E-4F91-8A54-DAFCCD55EF31 Q30416311-58B582A9-A32E-4876-B887-759941EECA23 Q30459497-39F3B1BF-7525-4135-BCAD-00A7BEB8D973 Q30462557-D02C4EE4-3D8D-4E1D-9EA0-EB50ABA71D10 Q30473327-AB9D099C-D2A9-40E5-AD02-332E295EE968 Q30474054-2020FF97-94A7-462F-A7DD-536629AEC5D7 Q30476813-89BBF151-0641-459A-AD4D-114F6DC958E0 Q30636304-55EEB584-699A-4F93-AC7F-33C843C81203 Q33523020-65EF68C0-81D5-4E92-84D5-CDFD52F1C596 Q33620649-424DA43B-A18C-4C59-803C-0C6D84DC526E Q33624771-B24EF4DA-CA1A-44A4-821F-861840415A2F Q33806745-A6A58345-2461-43EE-81D1-2B28911F28CB Q33844356-C7411A1E-CDDF-4943-BDEE-4C3B2EAA2816 Q34105209-41F0164F-3DA1-44F3-821B-0B9314A1CCBB Q34542229-6E25662F-A220-4858-987F-FA5B0A5898D0 Q34739659-AF7F9793-0491-4158-AEB9-F6113DCE5759 Q34788079-8497AFFC-D901-496B-B37D-4A3979A6B048 Q35229429-475D33A4-C3F8-494C-9B12-12978BF95121 Q35586514-C0DFA4A9-B09C-4BE2-9FED-D4BC86FE74DA Q35673126-49BFE011-EEC0-4694-BBE5-86F1ECA31252 Q35715224-0EC0C0A9-87FC-4F81-9BF3-B595B44944E8 Q36189837-B06DAD8E-5FEA-4D6A-B519-B5A3261DF586 Q36261104-D99D147B-ACAF-4C5F-BABD-56C882E6CE1E Q36740391-6D7DED77-1D05-4372-82E4-1B46FE4CD59B Q36838744-40BED17A-F977-418E-A359-51B4180A0138 Q37418017-B30FB75D-82E3-48C8-83DE-15509E272400 Q37428304-A24A35A5-5AB7-4E8B-ABB9-DACC93D28335 Q37618525-53740CDA-01A0-4713-85B9-0D23CAAA2B18 Q37643689-0745FA85-8169-4F20-8CBD-918574D131A2 Q38321358-577380AA-926A-4290-94E3-83653481EF0C Q38491087-606DADE6-0DAB-4EF6-B347-16C1FBE544CC

P2860

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

http://www.wikidata.org/entity/Q34578123

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@ast

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@en

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@nl

type

label

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@ast

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@en

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@nl

prefLabel

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@ast

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@en

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia.

@nl

P1433

Q34578123-4F432E70-887C-4609-8DA2-3994BDB8D153

P1476

Q34578123-5638F39B-9110-4A98-99CA-9A53063192AF

P2093

Q34578123-19C3EC66-FB9A-44A3-9AA9-9BD2640D6CC4

Q34578123-2958BD6C-2F01-4F36-92F7-BCB73A470DBD

Q34578123-2E2320C1-E28E-43F2-B155-D645632A076C

Q34578123-2FC91F9F-D6F2-4589-9DF6-1D317E3CFE8A

Q34578123-46E23EE9-B6EF-4706-857C-FAB3598FB7E4

Q34578123-4A8FCC82-D69E-4ECF-BFCD-1FB799B8852A

Q34578123-5547ECE8-C637-4405-863E-858BFACA2D47

Q34578123-633A7A5A-0E68-4A47-9620-EE7C32160A2A

Q34578123-65182679-4DAD-4D80-BBFC-6F040F92C83E

Q34578123-7472E83B-2FE5-4439-9925-34874720ACFF

P2888

Q34578123-683359AB-68C4-4EDB-A441-ECFBAF0A4646

P304

Q34578123-6DE444B5-A1B5-4EA0-9060-7EEF7B01D75A

P31

Q34578123-AC30DB19-F113-4A19-A46D-5474D2DB4608

P356

Q34578123-F93390D3-2613-4D5E-BA87-337AA849E83F

P407

Q34578123-5CF5A5D3-A3BA-4A80-B2AF-15A9A7362F8D

P433

Q34578123-F3D6BEA5-B2C6-4DAC-95EA-C868B6B13EDE

P478

Q34578123-7E2CF6A1-4B3D-4EE1-99A0-37FBEF0FFB7A

P50

Q34578123-5147E453-C48A-412E-BD58-0FF97CCE11FC

Q34578123-8D55B626-DF00-44D7-8732-6A08D3B1F8D4

Q34578123-970A7B05-A10D-4A05-B3C4-134EDCFFE8AD

Q34578123-A80F09AB-CDCA-4E99-9792-11822F29DF79

P577

Q34578123-E2B1360F-0FF4-4562-A726-158D696A4334

P5875

Q34578123-F1E9A936-145E-40FD-A2FD-A74F5D4394C8

P698

Q34578123-4C6B0281-9E6D-415F-9B97-53AD4AF63439

P921

Q34578123-F2910C05-7CFB-4832-8D9E-ECEA03C862E0

P356

P1433

Molecular Psychiatry

P1476

Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia

@en

P2093

Baba A

http://www.w3.org/2001/XMLSchema#string

Chiba S

http://www.w3.org/2001/XMLSchema#string

Hashimoto H

http://www.w3.org/2001/XMLSchema#string

Hashimoto R

http://www.w3.org/2001/XMLSchema#string

Hattori S

http://www.w3.org/2001/XMLSchema#string

Iwata N

http://www.w3.org/2001/XMLSchema#string

Kamijima K

http://www.w3.org/2001/XMLSchema#string

Kawagishi N

http://www.w3.org/2001/XMLSchema#string

Kosuga A

http://www.w3.org/2001/XMLSchema#string

Mori T

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1026-1032

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.MP.4001982

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Daniel R. Weinberger

P577

2007-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6420897

http://www.w3.org/2001/XMLSchema#string

P698

17387318

http://www.w3.org/2001/XMLSchema#string

P921